Sherin M. Zakaria
Al Mansurah, DK, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Clomipramine potentiates sorafenib efficacy in experimental hepatocellular carcinoma by targeting lysosomal sequestration and modulating the cathepsin B/Bcl-2/Beclin-1 axis.
Journal: Molecular biology reports
Published: April 12, 2026
Aescin ameliorates alcohol-induced liver injury. A possible implication of ROS / TNF-alpha / p38MAPK / caspase-3 signaling.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: September 07, 2024
Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS/ TGF-β / Smad4 signaling pathway.
Journal: Toxicology and applied pharmacology
Published: January 21, 2024
JNK inhibitor and ferroptosis modulator as possible therapeutic modalities in Alzheimer disease (AD).
Journal: Scientific reports
Published: January 12, 2024
OMA1 and YME1L as a Diagnostic Panel in Hepatocellular Carcinoma.
Journal: The Yale journal of biology and medicine
Published: January 01, 2024
Tissue Inhibitor Of Metalloproteinase 3 As A Potential Staging Biomarker In Hepatocellular Carcinoma.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: July 24, 2023
The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma.
Journal: Cell biochemistry and function
Published: April 19, 2023
Siah2 inhibitor and the metabolic antagonist Oxamate retard colon cancer progression and downregulate PD1 expression.
Journal: Recent patents on anti-cancer drug discovery
Published: May 25, 2022
Modulating the Siah2-PHD3-HIF1α axis and/or autophagy potentially retard colon cancer proliferation possibly, due to the damping of colon cancer stem cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2022
Perindopril sensitizes hepatocellular carcinoma to chemotherapy: A possible role of leptin / Wnt/ β-catenin axis with subsequent inhibition of liver cancer stem cells.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: February 07, 2022
Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats.
Journal: Life sciences
Published: October 19, 2021
Daidzein and Chicory Extract Arrest the Cell Cycle via Inhibition of Cyclin D/CDK4 and Cyclin A/CDK2 Gene Expression in Hepatocellular Carcinoma.
Journal: Recent patents on anti-cancer drug discovery
Published: September 13, 2021
Last Updated: 09/26/2026